Larvol Delta - Groundbreaking-results-in-Phase-2-scleroderma-study-by-Certa-Therapeutics-demonstrates-improvement-in-more-than-60-of-patients

FT011 - Certa Therap

https://www.prnewswire.com/news-releases/ground-breaking-results-in-phase-2-scleroderma-study-by-certa-therapeutics-demonstrates-improvement-in-more-than-60-of-patients-301738152.html

Feb 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next